Dr. Paul Parren - Gilde Healthcare

team
Venture&Growth

All team members
Dr. Paul Parren
Operational Partner
The Netherlands

Dr. Paul Parren

Operational Partner

Paul Parren is an internationally recognized antibody drug innovator and developer. Paul was Head of Preclinical Development and Research at Genmab (2002-2017), translating antibody biology successfully into immunotherapies from discovery to the clinic, including approved therapeutic antibodies ofatumumab and daratumumab, as well as establishing validated antibody platform technologies. He is a Professor of Molecular Immunology at the Leiden University Medical Center in Leiden, the Netherlands, board member of The Antibody Society and was an Associate Professor at The Scripps Research Institute in La Jolla, California. He holds a PhD in Molecular Immunology from the University of Amsterdam.

Paul assists Gilde in the evaluation of investment opportunities and is also acting as Executive Vice President and Head of Research & Development for Gilde’s portfolio company Lava Therapeutics.

Professor Dr. Rene Bernards

Operational Partner
Professor Dr René Bernards brings extensive experience in oncology as a researcher and a serial entrepreneur. He is a Professor at the Netherlands Cancer Institute (NKI). He performed his post-doctoral research at the Massachusetts Institute...

Zosia van Eesteren

Analyst
Venture&Growth
Zosia van Eesteren is a Dutch national who joined Gilde in 2022. She focuses on the Therapeutics sector and is responsible for analyzing both private and publicly traded companies. She is involved in the identification,...

Stacey Vrijhof

Management Assistant
Stacey Vrijhof joined Gilde Healthcare in 2023. As a Management Assistant she supports the team members of Gilde Healthcare. Before working at Gilde Healthcare, Stacey worked for an insurance company where she gained management experience....